$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 39.87 | 20,000 | 797,400 | 41,442 | 21.4 K to 41.4 K (+93.27 %) |
Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 84.00 | 2,240 | 188,160 | 21,442 | 23.7 K to 21.4 K (-9.46 %) |
Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 14.69 | 2,240 | 32,906 | 23,682 | 21.4 K to 23.7 K (+10.45 %) |
Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 84.02 | 24,000 | 2,016,593 | 21,442 | 45.4 K to 21.4 K (-52.81 %) |
Apr 10 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 47.34 | 24,000 | 1,136,160 | 45,442 | 21.4 K to 45.4 K (+111.93 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 61.68 | 2,252 | 138,903 | 7,969 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 49.25 | 8,000 | 394,000 | 46,638 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 47.34 | 5,600 | 265,104 | 20,825 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 61.57 | 2,657 | 163,591 | 0 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 61.68 | 20,365 | 1,256,113 | 10,221 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 61.68 | 7,654 | 472,099 | 30,586 | |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.75 | 2,252 | 190,857 | 16,673 | 18.9 K to 16.7 K (-11.90 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.68 | 2,252 | 138,903 | 18,925 | 16.7 K to 18.9 K (+13.51 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.25 | 1,878 | 158,222 | 16,673 | 18.6 K to 16.7 K (-10.12 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 82.01 | 1,122 | 92,015 | 18,551 | 19.7 K to 18.6 K (-5.70 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.29 | 8,000 | 674,320 | 19,673 | 27.7 K to 19.7 K (-28.91 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 49.25 | 8,000 | 394,000 | 27,673 | 19.7 K to 27.7 K (+40.66 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 82.10 | 3,600 | 295,560 | 19,673 | 23.3 K to 19.7 K (-15.47 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 47.34 | 3,600 | 170,424 | 23,273 | 19.7 K to 23.3 K (+18.30 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.20 | 2,000 | 168,400 | 19,673 | 21.7 K to 19.7 K (-9.23 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 47.34 | 2,000 | 94,680 | 21,673 | 19.7 K to 21.7 K (+10.17 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 82.03 | 2,657 | 217,954 | 19,673 | 22.3 K to 19.7 K (-11.90 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.57 | 2,657 | 163,591 | 22,330 | 19.7 K to 22.3 K (+13.51 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 82.19 | 4,873 | 400,512 | 19,673 | 24.5 K to 19.7 K (-19.85 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.68 | 4,873 | 300,567 | 24,546 | 19.7 K to 24.5 K (+24.77 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.75 | 15,492 | 1,312,947 | 19,673 | 35.2 K to 19.7 K (-44.06 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.68 | 15,492 | 955,547 | 35,165 | 19.7 K to 35.2 K (+78.75 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 84.83 | 7,654 | 649,289 | 19,673 | 27.3 K to 19.7 K (-28.01 %) |
Apr 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.68 | 7,654 | 472,099 | 27,327 | 19.7 K to 27.3 K (+38.91 %) |
Apr 02 2019 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 2,837,373 | 0 | 70,221,338 | 67.4 M to 70.2 M (+4.21 %) |
Mar 20 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 61.57 | 28,800 | 1,773,216 | 2,657 | |
Mar 20 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 78.79 | 28,800 | 2,269,187 | 19,673 | 48.5 K to 19.7 K (-59.41 %) |
Mar 20 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 61.57 | 28,800 | 1,773,216 | 48,473 | 19.7 K to 48.5 K (+146.39 %) |
Mar 20 2019 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Sell | S | 79.63 | 10,000 | 796,258 | 58,916 | 68.9 K to 58.9 K (-14.51 %) |
Mar 14 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 39.87 | 8,334 | 332,277 | 57,500 | |
Mar 14 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 75.00 | 8,334 | 625,050 | 52,677 | 61 K to 52.7 K (-13.66 %) |
Mar 14 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 39.87 | 8,334 | 332,277 | 61,011 | 52.7 K to 61 K (+15.82 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 39.87 | 8,333 | 332,237 | 65,834 | |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Sell | S | 70.00 | 8,333 | 583,310 | 52,677 | 61 K to 52.7 K (-13.66 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 39.87 | 8,333 | 332,237 | 61,010 | 52.7 K to 61 K (+15.82 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 39.87 | 8,000 | 318,960 | 0 | |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 47.34 | 18,800 | 889,992 | 4,755 | |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 68.75 | 8,000 | 550,000 | 19,673 | 27.7 K to 19.7 K (-28.91 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 39.87 | 8,000 | 318,960 | 27,673 | 19.7 K to 27.7 K (+40.66 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 68.75 | 14,100 | 969,375 | 19,673 | 33.8 K to 19.7 K (-41.75 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 47.34 | 14,100 | 667,494 | 33,773 | 19.7 K to 33.8 K (+71.67 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 64.51 | 4,700 | 303,205 | 19,673 | 24.4 K to 19.7 K (-19.28 %) |
Mar 01 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 47.34 | 4,700 | 222,498 | 24,373 | 19.7 K to 24.4 K (+23.89 %) |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 37,000 | 1,475,190 | 70,500 | |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 40,000 | 1,594,800 | 107,500 | |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 61.54 | 37,000 | 2,276,799 | 69,634 | 106.6 K to 69.6 K (-34.70 %) |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 37,000 | 1,475,190 | 106,634 | 69.6 K to 106.6 K (+53.13 %) |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 60.07 | 40,000 | 2,402,700 | 69,634 | 109.6 K to 69.6 K (-36.49 %) |
Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 40,000 | 1,594,800 | 109,634 | 69.6 K to 109.6 K (+57.44 %) |
Feb 14 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 39.87 | 275 | 10,964 | 8,000 | |
Feb 14 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 59.50 | 275 | 16,363 | 19,673 | 19.9 K to 19.7 K (-1.38 %) |
Feb 14 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 39.87 | 275 | 10,964 | 19,948 | 19.7 K to 19.9 K (+1.40 %) |
Feb 14 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Sell | S | 60.00 | 999 | 59,940 | 21,442 | 22.4 K to 21.4 K (-4.45 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 39.87 | 15,600 | 621,972 | 8,275 | |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 39.87 | 4,000 | 159,480 | 23,875 | |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 59.50 | 15,600 | 928,200 | 19,673 | 35.3 K to 19.7 K (-44.23 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 39.87 | 15,600 | 621,972 | 35,273 | 19.7 K to 35.3 K (+79.30 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 58.29 | 4,000 | 233,160 | 19,673 | 23.7 K to 19.7 K (-16.90 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 39.87 | 4,000 | 159,480 | 23,673 | 19.7 K to 23.7 K (+20.33 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 14.69 | 9,013 | 132,401 | 0 | |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 58.29 | 9,013 | 525,368 | 24,528 | 33.5 K to 24.5 K (-26.87 %) |
Feb 05 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 14.69 | 9,013 | 132,401 | 33,541 | 24.5 K to 33.5 K (+36.75 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 0.00 | 7,822 | 0 | 14,463 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 0.00 | 20,797 | 0 | 20,797 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Payment of Exercise | F | 58.26 | 2,818 | 164,177 | 24,400 | 27.2 K to 24.4 K (-10.35 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 0.00 | 7,822 | 0 | 27,218 | 19.4 K to 27.2 K (+40.33 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 8,085 | 0 | 15,048 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 0.00 | 25,730 | 0 | 25,730 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Payment of Exercise | F | 58.26 | 2,908 | 169,420 | 22,034 | 24.9 K to 22 K (-11.66 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 8,085 | 0 | 24,942 | 16.9 K to 24.9 K (+47.96 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Option Exercise | M | 0.00 | 7,891 | 0 | 14,463 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Option Exercise | A | 0.00 | 22,131 | 0 | 22,131 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Payment of Exercise | F | 58.26 | 2,842 | 165,575 | 19,823 | 22.7 K to 19.8 K (-12.54 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Buy | M | 0.00 | 7,891 | 0 | 22,665 | 14.8 K to 22.7 K (+53.41 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 0.00 | 10,006 | 0 | 20,280 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | A | 0.00 | 45,728 | 0 | 45,728 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Payment of Exercise | F | 58.26 | 3,572 | 208,105 | 22,275 | 25.8 K to 22.3 K (-13.82 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 0.00 | 10,006 | 0 | 25,847 | 15.8 K to 25.8 K (+63.17 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 2,346 | 0 | 4,612 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 30,587 | 0 | 48,077 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 5,332 | 0 | 5,332 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 63,726 | 0 | 63,726 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Payment of Exercise | F | 58.26 | 942 | 54,881 | 5,532 | 6.5 K to 5.5 K (-14.55 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 2,346 | 0 | 6,474 | 4.1 K to 6.5 K (+56.83 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Payment of Exercise | F | 58.26 | 12,686 | 739,086 | 69,634 | 82.3 K to 69.6 K (-15.41 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 30,587 | 0 | 82,320 | 51.7 K to 82.3 K (+59.12 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 0.00 | 7,823 | 0 | 14,466 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | A | 0.00 | 22,131 | 0 | 22,131 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Payment of Exercise | F | 58.26 | 2,734 | 159,283 | 19,607 | 22.3 K to 19.6 K (-12.24 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 0.00 | 7,823 | 0 | 22,341 | 14.5 K to 22.3 K (+53.88 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Option Exercise | A | 0.00 | 13,065 | 0 | 13,065 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 20,656 | 0 | 35,100 | |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Payment of Exercise | F | 58.26 | 6,159 | 358,823 | 52,677 | 58.8 K to 52.7 K (-10.47 %) |
Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 20,656 | 0 | 58,836 | 38.2 K to 58.8 K (+54.10 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 39.87 | 4,000 | 159,480 | 27,875 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | M | 10.82 | 400 | 4,328 | 0 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Option Exercise | A | 53.77 | 49,800 | 2,677,746 | 49,800 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 54.80 | 4,000 | 219,200 | 14,584 | 18.6 K to 14.6 K (-21.52 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 39.87 | 4,000 | 159,480 | 18,584 | 14.6 K to 18.6 K (+27.43 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Sell | S | 54.80 | 400 | 21,920 | 14,584 | 15 K to 14.6 K (-2.67 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | M | 10.82 | 400 | 4,328 | 14,984 | 14.6 K to 15 K (+2.74 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP Legal & General ... | Buy | J | 36.45 | 66 | 2,406 | 14,584 | 14.5 K to 14.6 K (+0.45 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | McDevitt Damien | Chief Business Offi ... | Option Exercise | A | 53.77 | 29,400 | 1,580,838 | 29,400 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Option Exercise | A | 53.77 | 49,800 | 2,677,746 | 49,800 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP Finance & CFO | Buy | J | 36.45 | 127 | 4,629 | 14,901 | 14.8 K to 14.9 K (+0.86 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | A | 53.77 | 102,900 | 5,532,933 | 102,900 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 53.50 | 214 | 11,449 | 15,837 | 16.1 K to 15.8 K (-1.33 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | J | 36.45 | 210 | 7,654 | 16,051 | 15.8 K to 16.1 K (+1.33 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 53.77 | 57,900 | 3,113,283 | 57,900 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 36.45 | 407 | 14,834 | 17,264 | 16.9 K to 17.3 K (+2.41 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | A | 53.77 | 46,800 | 2,516,436 | 46,800 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 36.45 | 128 | 4,665 | 19,524 | 19.4 K to 19.5 K (+0.66 %) |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 53.77 | 12,000 | 645,240 | 12,000 | |
Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 53.77 | 143,400 | 7,710,618 | 143,400 | |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 7.25 | 2,063 | 14,957 | 0 | |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 7.25 | 2,000 | 14,500 | 2,063 | |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 52.05 | 2,063 | 107,379 | 14,774 | 16.8 K to 14.8 K (-12.25 %) |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 7.25 | 2,063 | 14,957 | 16,837 | 14.8 K to 16.8 K (+13.96 %) |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 52.00 | 2,000 | 104,000 | 14,774 | 16.8 K to 14.8 K (-11.92 %) |
Dec 20 2018 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 7.25 | 2,000 | 14,500 | 16,774 | 14.8 K to 16.8 K (+13.54 %) |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 14.69 | 34,000 | 499,460 | 0 | |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 14.69 | 34,000 | 499,460 | 0 | |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 55.00 | 34,000 | 1,870,058 | 15,841 | 49.8 K to 15.8 K (-68.22 %) |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 55.00 | 34,000 | 1,870,058 | 15,841 | 49.8 K to 15.8 K (-68.22 %) |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 14.69 | 34,000 | 499,460 | 49,841 | 15.8 K to 49.8 K (+214.63 %) |
Nov 26 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 14.69 | 34,000 | 499,460 | 49,841 | 15.8 K to 49.8 K (+214.63 %) |
Nov 01 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 14.69 | 12,500 | 183,625 | 9,013 | |
Nov 01 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 49.54 | 12,500 | 619,245 | 19,396 | 31.9 K to 19.4 K (-39.19 %) |
Nov 01 2018 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 14.69 | 12,500 | 183,625 | 31,896 | 19.4 K to 31.9 K (+64.45 %) |
Oct 18 2018 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,671,849 | 0 | 67,383,965 | 65.7 M to 67.4 M (+2.54 %) |
Oct 18 2018 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 1,671,849 | 0 | 67,383,965 | 65.7 M to 67.4 M (+2.54 %) |
Oct 15 2018 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
Oct 15 2018 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
Oct 15 2018 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
Oct 15 2018 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 0.00 | 7,110 | 0 | 7,110 | |
Sep 24 2018 | ISIS | IONIS PHARMACEUTIC ... | Hayden Michael R | Director | Option Exercise | A | 50.80 | 32,000 | 1,625,600 | 32,000 | |
Sep 24 2018 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 49.14 | 32,000 | 1,572,480 | 32,000 | |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 7.21 | 7,500 | 54,075 | 0 | |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 7.25 | 8,993 | 65,199 | 0 | |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 54.00 | 7,500 | 405,000 | 15,841 | 23.3 K to 15.8 K (-32.13 %) |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 7.21 | 7,500 | 54,075 | 23,341 | 15.8 K to 23.3 K (+47.35 %) |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Sell | S | 54.00 | 8,993 | 485,622 | 15,841 | 24.8 K to 15.8 K (-36.21 %) |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Buy | M | 7.25 | 8,993 | 65,199 | 24,834 | 15.8 K to 24.8 K (+56.77 %) |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 7.21 | 7,500 | 54,075 | 0 | |
Aug 29 2018 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Operating Off ... | Option Exercise | M | 7.25 | 8,993 | 65,199 | 0 |